Moderately Elevated Lp(a) Associated With Higher CV Risk Tags Lipoproteins Read more about Moderately Elevated Lp(a) Associated With Higher CV Risk
Greater Relative Cardiovascular Benefit From LDL-C Lowering Observed in Lower-Risk Primary Prevention Populations Tags Hypercholesterolemia Lipoproteins Read more about Greater Relative Cardiovascular Benefit From LDL-C Lowering Observed in Lower-Risk Primary Prevention Populations
Meta-analysis Found Nearly 60% LDL-C Reduction With Oral PCSK9 Inhibitors Tags Lipoproteins TPHT_others Read more about Meta-analysis Found Nearly 60% LDL-C Reduction With Oral PCSK9 Inhibitors
Oral PCSK9 Inhibitor Laroprovstat Reduced LDL-C by Up to 80% With Statin Therapy Tags Hypercholesterolemia Lipoproteins Read more about Oral PCSK9 Inhibitor Laroprovstat Reduced LDL-C by Up to 80% With Statin Therapy
Enlicitide Outperformed Oral Nonstatins in LDL-C Lowering Tags Lipoproteins Hypercholesterolemia Read more about Enlicitide Outperformed Oral Nonstatins in LDL-C Lowering
Sex-Specific Lipid Markers Linked with Aortic Stenosis Risk Tags Aortic Stenosis Hypercholesterolemia Hypobeta alipoprotenemia Lipoproteins Read more about Sex-Specific Lipid Markers Linked with Aortic Stenosis Risk
Non-Statin Therapies Improved LDL-C in Heart Transplant Care Tags Cardiac Transplantation Heart Failure Hypercholesterolemia Lipoproteins TPHT_others Triglycerides Read more about Non-Statin Therapies Improved LDL-C in Heart Transplant Care
Do Childhood-to-Adult Weight Gains Raise CVD Risk Most? Tags Heart Failure Ischemic Stroke Lipoproteins Metabolic Syndrome Read more about Do Childhood-to-Adult Weight Gains Raise CVD Risk Most?
High Lp(a) Tied to High-Risk Coronary Plaque Features on CCTA Tags Lipoproteins Hypercholesterolemia Coronary Angiography CT scan DCAD_others Read more about High Lp(a) Tied to High-Risk Coronary Plaque Features on CCTA
ACC 2026: Enlicitide Shows Superior LDL-C Reduction vs Oral Nonstatin Therapies Tags Triglycerides Hypercholesterolemia Read more about ACC 2026: Enlicitide Shows Superior LDL-C Reduction vs Oral Nonstatin Therapies